Stock

Ovid Therapeutics Inc. OVID

$2.33-2.92%

All stocks Create account to unlock

Overview

OVID market data

Price History

OVID price chart

Valuation & Profitability

no valuation data

No Valuation Data Yet

Alpha Vantage and Twelve Data both returned no valuation metrics for OVID. Check back after the next daily valuation refresh — this symbol may be new, delisted, or temporarily unavailable from both providers.

Company news

4 captured

Ovid Therapeutics Promotes Charles Carter As CFO Succeeding Jeffrey Rona · Jul 8, 2026, 11:35 AM

8-K filing — Ovid Therapeutics Inc. (OVID) · Jul 8, 2026, 11:03 AM

Rivian, Micron And Other Big Stocks Moving Lower In Tuesday’s Pre-Market Session · Jul 7, 2026, 12:05 PM

uniQure's Experimental Drug Shows Early Promise In Difficult-To-Treat Epilepsy · Jun 22, 2026, 3:55 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock